GlassScriptPhysician profile
Mark Allen Williams
NPI 1023786225
$2,543.52
in general payments reported to CMS, 2019-2025
17 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $663 · 2023: $769 · 2024: $574 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,881.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $619.09 | 2022-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $336.87 | 2022-2024 | Austedo Xr, Austedo, Uzedy |
| Abbvie INC. | $326.14 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $295.80 | 2022-2024 | Invega, Spravato |
| Otsuka America Pharmaceutical, INC. | $231.98 | 2022-2024 | Rexulti, Abilify Mycite, Abilify Asimtufii |
| Lundbeck LLC | $117.96 | 2023-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $109.66 | 2022-2025 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $105.54 | 2022 | |
| Alkermes, INC. | $97.17 | 2022-2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $74.60 | 2025 | Cobenfy |
| Braeburn INC. | $56.94 | 2023-2025 | Brixadi |
| Idorsia Pharmaceuticals US INC | $41.71 | 2023-2024 | Quviviq |
| Corium, LLC | $41.65 | 2022-2023 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $32.95 | 2022-2023 | Trintellix |
| Almatica Pharma LLC | $20.96 | 2024 | Loreev Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $19.86 | 2024 | Medline, Remedy Essentials |
| Indivior INC. | $14.64 | 2023 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.